• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定性封装人心肌干细胞于可变组成纳米多孔凝胶茧中以增强受损心肌的治疗性修复。

Deterministic Encapsulation of Human Cardiac Stem Cells in Variable Composition Nanoporous Gel Cocoons To Enhance Therapeutic Repair of Injured Myocardium.

机构信息

University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine , University of Ottawa , Ottawa , Canada K1Y4W7.

Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute , University of Ottawa , Ottawa , Canada K1Y4W7.

出版信息

ACS Nano. 2018 May 22;12(5):4338-4350. doi: 10.1021/acsnano.7b08881. Epub 2018 Apr 20.

DOI:10.1021/acsnano.7b08881
PMID:29660269
Abstract

Although cocooning explant-derived cardiac stem cells (EDCs) in protective nanoporous gels (NPGs) prior to intramyocardial injection boosts long-term cell retention, the number of EDCs that finally engraft is trivial and unlikely to account for salutary effects on myocardial function and scar size. As such, we investigated the effect of varying the NPG content within capsules to alter the physical properties of cocoons without influencing cocoon dimensions. Increasing NPG concentration enhanced cell migration and viability while improving cell-mediated repair of injured myocardium. Given that the latter occurred with NPG content having no detectable effect on the long-term engraftment of transplanted cells, we found that changing the physical properties of cocoons prompted explant-derived cardiac stem cells to produce greater amounts of cytokines, nanovesicles, and microRNAs that boosted the generation of new blood vessels and new cardiomyocytes. Thus, by altering the physical properties of cocoons by varying NPG content, the paracrine signature of encapsulated cells can be enhanced to promote greater endogenous repair of injured myocardium.

摘要

虽然在心肌内注射前将茧状衍生的心脏干细胞 (EDCs) 包埋在保护性纳米多孔凝胶 (NPG) 中可以提高细胞的长期保留率,但最终植入的 EDC 数量微不足道,不太可能对心肌功能和疤痕大小产生有益影响。因此,我们研究了改变胶囊内 NPG 含量以改变茧的物理性质而不影响茧尺寸的效果。增加 NPG 浓度可以提高细胞迁移和活力,同时改善细胞介导的损伤心肌修复。鉴于后者发生时,NPG 含量对移植细胞的长期植入没有可检测到的影响,我们发现改变茧的物理性质促使衍生自外植体的心脏干细胞产生更多的细胞因子、纳米囊泡和 microRNAs,从而促进新血管和新心肌细胞的生成。因此,通过改变 NPG 含量来改变茧的物理性质,可以增强包裹细胞的旁分泌特征,从而促进损伤心肌的更大程度的内源性修复。

相似文献

1
Deterministic Encapsulation of Human Cardiac Stem Cells in Variable Composition Nanoporous Gel Cocoons To Enhance Therapeutic Repair of Injured Myocardium.确定性封装人心肌干细胞于可变组成纳米多孔凝胶茧中以增强受损心肌的治疗性修复。
ACS Nano. 2018 May 22;12(5):4338-4350. doi: 10.1021/acsnano.7b08881. Epub 2018 Apr 20.
2
Deterministic paracrine repair of injured myocardium using microfluidic-based cocooning of heart explant-derived cells.利用基于微流控技术的心脏外植体来源细胞包封实现对损伤心肌的确定性旁分泌修复。
Biomaterials. 2020 Jul;247:120010. doi: 10.1016/j.biomaterials.2020.120010. Epub 2020 Apr 2.
3
Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.利用胰岛素样生长因子1对人心脏干细胞进行旁分泌工程可增强心肌修复。
J Am Heart Assoc. 2015 Sep 11;4(9):e002104. doi: 10.1161/JAHA.115.002104.
4
Paracrine Engineering of Human Explant-Derived Cardiac Stem Cells to Over-Express Stromal-Cell Derived Factor 1α Enhances Myocardial Repair.对人外植体来源的心脏干细胞进行旁分泌工程改造以过度表达基质细胞衍生因子1α可增强心肌修复。
Stem Cells. 2016 Jul;34(7):1826-35. doi: 10.1002/stem.2373. Epub 2016 Apr 21.
5
Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.挤出的间充质干细胞纳米囊泡在心脏修复中与天然细胞外囊泡同样有效。
ACS Appl Mater Interfaces. 2021 Dec 1;13(47):55767-55779. doi: 10.1021/acsami.1c08044. Epub 2021 Nov 18.
6
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.多能干细胞衍生的心肌细胞的旁分泌作用挽救受损心肌。
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
7
Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.白细胞介素-6 通过心脏组织块来源的干细胞介导梗死修复。
Theranostics. 2017 Oct 17;7(19):4850-4861. doi: 10.7150/thno.19435. eCollection 2017.
8
Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.胚胎干细胞衍生的外泌体可促进内源性修复机制,并增强心肌梗死后的心脏功能。
Circ Res. 2015 Jun 19;117(1):52-64. doi: 10.1161/CIRCRESAHA.117.305990. Epub 2015 Apr 22.
9
Activation of Endogenous Cardiac Stem Cells by Apelin-13 in Infarcted Rat Heart.Apelin-13对梗死大鼠心脏内源性心脏干细胞的激活作用
Cell Transplant. 2016;25(9):1645-1652. doi: 10.3727/096368916X691123. Epub 2016 Feb 26.
10
Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair.源自小肠黏膜下层的凝胶作为可注射生物材料在心肌梗死修复中的差异疗效。
Biomaterials. 2010 Oct;31(30):7678-83. doi: 10.1016/j.biomaterials.2010.06.056. Epub 2010 Jul 31.

引用本文的文献

1
Targeting extracellular vesicle delivery to the lungs by microgel encapsulation.通过微凝胶包封将细胞外囊泡递送至肺部
J Extracell Biol. 2023 May 31;2(6):e94. doi: 10.1002/jex2.94. eCollection 2023 Jun.
2
Prevention of atrial fibrillation after open-chest surgery with extracellular vesicle therapy.细胞外囊泡治疗预防开胸手术后心房颤动。
JCI Insight. 2023 Jun 29;8(15):e163297. doi: 10.1172/jci.insight.163297.
3
Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy.
生物材料辅助生物疗法:用于药物递送、疫苗开发、基因治疗和干细胞治疗的生物材料简要综述。
Bioact Mater. 2022 Jan 19;17:29-48. doi: 10.1016/j.bioactmat.2022.01.011. eCollection 2022 Nov.
4
Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions.治疗受损心脏的药物递送方式:当前挑战与新兴解决方案
Front Cardiovasc Med. 2021 Sep 28;8:742315. doi: 10.3389/fcvm.2021.742315. eCollection 2021.
5
State-of-play for cellular therapies in cardiac repair and regeneration.心脏修复与再生中细胞疗法的现状
Stem Cells. 2021 Dec;39(12):1579-1588. doi: 10.1002/stem.3446. Epub 2021 Aug 27.
6
Electrophysiological engineering of heart-derived cells with calcium-dependent potassium channels improves cell therapy efficacy for cardioprotection.钙依赖性钾通道的心脏来源细胞的电生理工程改善了心脏保护细胞治疗的效果。
Nat Commun. 2021 Aug 16;12(1):4963. doi: 10.1038/s41467-021-25180-8.
7
All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart.条条大路通罗马(心脏):细胞疗法产品通过各种途径输送到心脏后的细胞保留和结果。
J Am Heart Assoc. 2021 Apr 20;10(8):e020402. doi: 10.1161/JAHA.120.020402. Epub 2021 Apr 6.
8
Injectable Hydrogels for Improving Cardiac Cell Therapy-In Vivo Evidence and Translational Challenges.用于改善心脏细胞治疗的可注射水凝胶——体内证据与转化挑战
Gels. 2021 Jan 22;7(1):7. doi: 10.3390/gels7010007.
9
Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium.人心细胞的生理性扩张增强了受损心肌的治疗性修复。
Stem Cell Res Ther. 2019 Nov 4;10(1):316. doi: 10.1186/s13287-019-1418-3.
10
Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction.一氧戊二醛 1 可预防慢性高血糖诱导的心脏外植体细胞功能障碍。
Theranostics. 2019 Aug 9;9(19):5720-5730. doi: 10.7150/thno.36639. eCollection 2019.